Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Intradermal Injections of RCS-01 in Male and Female Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02391935
Recruitment Status : Completed
First Posted : March 18, 2015
Last Update Posted : October 11, 2017
Sponsor:
Collaborators:
JensonR+ Limited
PHARMALOG Institut für klinische Forschung GmbH
Syreon Corporation
Innovacell Biotechnologie AG
Datinf GmbH
Information provided by (Responsible Party):
RepliCel Life Sciences, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 12, 2017
Actual Study Completion Date : July 12, 2017